Today: 10 June 2026
Marvell stock whipsaws after $540 million XConn deal puts AI data-center switching in focus
6 January 2026
1 min read

Marvell stock whipsaws after $540 million XConn deal puts AI data-center switching in focus

New York, January 6, 2026, 13:09 ET — Regular session

  • Marvell said it will buy XConn Technologies for about $540 million in a cash-and-stock deal.
  • MRVL shares were down about 1% in afternoon trade after swinging between $87.64 and $94.15.
  • Marvell expects XConn products to start adding revenue in the second half of fiscal 2027 and reach about $100 million by fiscal 2028.

Marvell Technology, Inc. said on Tuesday it will acquire XConn Technologies for about $540 million, a bet on the high-speed links that stitch together AI data centers. Marvell shares were down about 1.1% at $89.26 after earlier rising as much as 4.3% and then turning lower.

The move lands as chipmakers race to ease data bottlenecks inside AI servers, where moving information between chips can be as critical as raw compute. Switching silicon — chips that steer data traffic — can shape how quickly an AI model trains and how much power a cluster consumes.

XConn makes switching chips built around PCI Express (PCIe) and Compute Express Link (CXL), two standards used inside servers to connect processors, accelerators and memory. Marvell said the acquisition will also bolster its Ultra Accelerator Link (UALink) effort, an open standard aimed at linking many accelerators so they can act like one larger system.

Marvell said it will pay roughly 60% of the purchase price in cash and 40% in stock, with the stock component set using the company’s 20-day volume-weighted average price (VWAP), a trading-volume-weighted measure of average price. Chief executive Matt Murphy said the combination would create “a compelling switching platform,” while XConn CEO Gerry Fan said the companies share “a common vision” for high-speed connectivity. Marvell Technology, Inc.

The company said XConn is engaged with more than 20 customers, with PCIe 5 and CXL 2.0 switches already in production and PCIe 6 and CXL 3.1 products sampling. Marvell also said the deal adds engineers with experience in high-performance switching.

Marvell expects XConn products to begin contributing revenue in the second half of fiscal 2027 and to ramp to about $100 million in fiscal 2028, with the business becoming accretive to non-GAAP earnings — a profit measure that excludes certain items such as some acquisition-related costs. Analysts expect Marvell to record $12.75 billion in revenue in fiscal 2027, according to LSEG data, as it competes with larger rivals including Broadcom and Nvidia in data-center gear.

Chip and AI-linked stocks have drawn fresh attention this week as CES events in Las Vegas put new products and spending plans under the microscope, with investors still debating how quickly big AI outlays will translate into cash returns.

Still, the deal carries execution risk. Any delay in regulatory clearance, integration hiccups, or slower adoption of newer standards such as UALink could push out the revenue ramp, while a pullback in AI infrastructure spending would test demand for networking and connectivity parts.

Investors will watch for any further management commentary tied to CES through January 9, and for details on closing conditions as Marvell targets an early-2026 close for the transaction.

Stock Market Today

  • Palantir Technologies (PLTR) Shares Seen Fairly Valued Amid Recent Decline
    June 10, 2026, 5:48 PM EDT. Palantir Technologies has seen its share price fall 13.2% over the past week and 21.3% year to date, following extraordinary gains in prior years. At $132.07 per share, Palantir trades slightly below its estimated intrinsic value of $145.11 based on a Discounted Cash Flow (DCF) analysis, suggesting a modest 9% discount. The company posted $2.69 billion in free cash flow over the past twelve months, with projections rising to $16.11 billion by 2030. Despite recent volatility tied to sentiment on artificial intelligence and software spending, Palantir remains fairly valued but not a clear bargain. Investors should monitor further market developments and valuation metrics to gauge future opportunities or risks.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Fermi Inc (FRMI) stock jumps nearly 10% as class-action filing adds pressure
Previous Story

Fermi Inc (FRMI) stock jumps nearly 10% as class-action filing adds pressure

Merck stock hits 52-week high as vaccine policy shift and JPM conference loom
Next Story

Merck stock hits 52-week high as vaccine policy shift and JPM conference loom

Go toTop